obesity-2016_scientifictracks-abstracts

14 / 20

Volume 6, Issue 9(Suppl) J Obes Weight Loss Ther 2016
ISSN: 2165-7904 JOWT, an open access journal
Page 37
Notes:
Obesity 2016
December 08-10, 2016
conferenceseries.com
Obesity & Weight Management
December 08-10, 2016 Dallas, USA
10th International Conference and Exhibition on
Treatment modalities potentially suitable for patients with hedonic obesity
Yi-Hao Yu
Greenwich Hospital, USA
Hedonic obesity is caused by persistent overeating driven by hedonic hunger resulting from dysfunctional neural circuitries that
govern reward and emotion. Excessive food intake in this case is a consequence of complicated food-seeking behavior to achieve
reward and satisfaction, rather than to meet energy needs. If there were non-caloric foods that can satisfy patients’ hedonic needs
without adding calories, there would be no obesity issue in this subpopulation of patients. This is in contrast to metabolic obesity,
in which the obese weight is sustained because of the increased caloric needs demanded by an elevated body weight set point. In
metabolic obesity, if patients take in less calories than what are required to maintain the homeostatic set point, their bodies would
respond by conserving energy and constantly seeking for more calories; they would be constantly hungry until the obese body weight
is restored. In this presentation, I'll discuss some of the future treatment options, mostly still in the pipeline at this time which would
allow food intake to satisfy hedonic needs and reward but prevent excessive caloric assimilation. These treatment options will most
likely be successful in the subpopulation of patients who have hedonic obesity.
Biography
Yi-Hao Yu is an Endocrinologist of Northeast Medical Group, Yale-New Haven Health System, Connecticut, USA. He is Medical Director of Center for Behavioral & Nutrition
Health and Inpatient Diabetes Program at Greenwich Hospital. Previously, he was Faculty of several universities and served as Director of Nutrition Services at Columbia
Presbyterian Hospital, Director of Nutrition Fellowship Program at Columbia University and Medical Director of Discovery Medicine & Clinical Pharmacology at Bristol-Myers
Squibb Company. He completed his MD and PhD at NYU School of Medicine. He has published more than 20 original research papers in the top-notch medical and scientific
journals and many reviews/book chapters in the field of “Diabetes, obesity and associated metabolic disorders”.
Yi-Hao Yu, J Obes Weight Loss Ther 2016, 6:9(Suppl)